Supplementary Online Content
|
|
- Shon Webb
- 5 years ago
- Views:
Transcription
1 Supplementry Online Content DeJong C, Aguilr T, Tseng CW, Lin GA, Boscrdin WJ, Dudley RA. Phrmceuticl industry sponsored mels nd physicin prescriing ptterns for Medicre eneficiries. JAMA Intern Med. Pulished online June 20, doi: /jminternmed etle 1. Medictions in the Four Trget Drug Ctegories efigure. Study Flow Digrm etle 2. Chrcteristics of Physicins in the Study Popultion etle 3. Predictors of Trget-Drug Prescriing, Adjusted for Averge Cost per Mel etle 4. Propensity Score Decile-Adjusted Odds Rtios for Prescriing the Trget Drug etle 5. Results of Flsifiction Test: The Effect of Rosuvsttin Mels on Desvenlfxine Prescriing, nd the Effect of Desvenlfxine Mels on Rosuvsttin Prescriing etle 6. Predictors of Trget Drug Prescriing, with Low-Volume Prescriers Excluded etle 7. Predictors of Trget Drug Prescriing, with Clim Count Stndrdized to 30-Dy Supplies etle 8. Predictors of Rosuvsttin Prescriing s Percentge of High-Intensity Sttin Prescriptions This supplementry mteril hs een provided y the uthors to give reders dditionl informtion out their work Americn Medicl Assocition. All rights reserved. Downloded From: on 10/13/2018
2 etle 1. Medictions in the Four Trget Drug Ctegories Sttins Crdioselective ACE inhiitors nd ARBs SSRIs nd SNRIs Β-Blockers ACE inhiitors ARBs SSRIs SNRIs Crestor (Rosuvsttin) Bystolic (Neivolol) Benzepril HCL Benicr (Olmesrtn) Citloprm HBR Pristiq ER (Desvenlfxine succ.) Livlo Atenolol Lotensin Diovn (Vlsrtn) Celex (Citloprm) Desvenlfxine se (Pitvsttin) (Benzepril) Atorvsttin Tenormin Cptopril Edri (Azilsrtn) Escitloprm oxlte Khedezl Clcium (Atenolol) (Desvenlfxine se) Lipitor (Atorvsttin) Betxolol HCL Cpoten (Cptopril) Cndesrtn cilexetil Lexpro (Escitloprm) Duloxetine HCL Simvsttin Kerlone (Betxolol) Enlpril mlete Atcnd (Cndesrtn) Fluoxetine DR Cymlt (Duloxetine) Zocor (Simvsttin) Bisoprolol fumrte Vsotec (Enlpril) Eprosrtn Fluoxetine HCL Venlfxine HCL Fluvsttin Sodium Zeet (Bisoprolol) Fosinopril Sodium Teveten (Eprosrtn) Prozc (Fluoxetine) Effexor (Venlfxine) Lescol (Fluvsttin) Metoprolol trtrte Monopril (Fosinopril) Iresrtn Prozc Weekly (Fluoxetine) Effexor XR (Venlfxine) Lescol XL (Fluvsttin) Lopressor (Metop. trtrte) Lisinopril Avpro (Iresrtn) Proxetine HCL Fetzim (Levomilnciprn) Lovsttin Metoprolol succinte Prinivil (Lisinopril) Losrtn potssium Pxil (Proxetine) Altoprev (Lovsttin) Toprol XL (Metop. succinte) Zestril (Lisinopril) Cozr (Losrtn) Pxil CR (Proxetine) Mevcor (Lovsttin) Moexipril HCL Micrdis (Telmisrtn) Pexev (Proxetine) Prvsttin Sodium Univsc (Moexipril) Sertrline HCL Prvchol Perindopril erumine Zoloft (Sertrline) (Prvsttin) Aceon (Perindopril) Quinpril HCL Accupril (Quinpril) Rmipril Altce (Rmipril) Trndolpril Mvik (Trndolpril) Epned (Enlpril) Medictions excluded from the four trget drug ctegories - Breviloc (Esmolol) c Enlprilt (Enlpril) c - Srfem (Fluoxetine) d Vsotec IV Brisdelle (Enlpril) c (Proxetine) d Irenk (Duloxetine) e Desvenlfxine fumrte e Inhice (Cilzpril) g Brintellix (Vortioxetine) f Svell (Milnciprn) d Viiryd (Vilzodone) f Drugs were identified using Lexi-Drugs (Lexicomp) Phrmcologic Ctegories. We included ll formultions nd excluded comintion pills. ACE denotes ngiotensin-converting enzyme, ARB ngiotensin-receptor locker, SNRI serotonin-norepinephrine reuptke inhiitor, nd SSRI selective serotonin-reuptke inhiitor. Denotes generic mediction c Not ville orlly d Not FDA-pproved for the trget drug ctegory s primry indiction (depression [SSRIs nd SNRIs], hyperlipidemi [sttins], nd hypertension [ACE inhiitors, ARBs, nd β-lockers]). e FDA-pproved fter f Excluded for mjor phrmcologic difference: in ddition to cting s selective serotonin reuptke inhiitor, vortioxetine (Brintellix ) is 5-HT 1A nd 5- HT 3 receptor gonist nd vilzodone (Viiryd ) is 5-HT 1A receptor prtil gonist. g Not ville in the U.S Americn Medicl Assocition. All rights reserved. Downloded From: on 10/13/2018
3 efigure. Study Flow Digrm 533,919 physicins identified in the Medicre Prt D Prescrier dtset 279,669 physicins in the study popultion 254,250 were excluded from the study popultion - 189,278 hd rnded clim count redcted y CMS - 63,562 did not mtch with Physicin Compre - 1,232 hd identicl mtching criteri excluded for medicl school grdution yer post-2013 or pre-1910 (presumed inccurcy) 155,849 physicins met inclusion criteri for t lest one of four study groups: 131,207 wrote more thn 20 filled sttin prescriptions 126,134 wrote more thn 20 filled crdioselective β- locker prescriptions 131,343 wrote more thn 20 filled ACE inhiitor or ARB prescriptions 123,318 wrote more thn 20 filled SSRI or SNRI prescriptions 19,619 were excluded from the regression smple - 11,382 received untgged or non-mel trget pyments - 4,360 missing Med. HH Inc. - 1,957 missing Pop. Density - 3 missing Census Region -1,577 missing MA-PD count missing LIS count 9,778 were excluded from the regression smple - 1,952 received untgged or non-mel trget pyments - 4,226 missing Med. HH Inc. - 1,888 missing Pop. Density - 2 missing Census Region - 1,477 missing MA-PD count missing LIS count 10,024 were excluded from the regression smple - 1,529 received untgged or non-mel trget pyments - 4,514 missing Med. HH Inc. - 2,018 missing Pop. Density - 3 missing Census Region - 1,614 missing MA-PD count missing LIS count 9,334 were excluded from the regression smple - 1,884 received untgged or non-mel trget pyments - 3,843 missing Med. HH Inc. - 1,543 missing Pop. Density - 3 missing Census Region - 1,599 missing MA-PD count missing LIS count 111,588 sttin prescriers included in the regression nlysis 116,356 β-locker prescriers included in the regression nlysis 121,319 ACE inhiitor nd ARB prescriers included in the regression nlysis 113,984 SSRI nd SNRI prescrie included in the regression nlysis Med. HH Inc. refers to medin household income; Pop. Density refers to urn or rurl sttus; MA-PD Count refers to proportion of totl prescriptions written for Medicre Advntge Prt D eneficiries; nd LIS Count refers to the proportion of totl prescriptions written for low-income susidy eneficiries. These physicins resided outside of ny U.S. Census Region (e.g. in Puerto Rico) Americn Medicl Assocition. All rights reserved. Downloded From: on 10/13/2018
4 etle 2. Chrcteristics of Physicins in the Study Popultion (N = 279,669) Demogrphic chrcteristics Physicins receiving no pyments (N=134,865) Physicins receiving pyments (N=144,804) P-vlue c Gender <0.001 Mle (%) Femle (%) Specilty (%) <0.001 Internl medicine Fmily medicine nd generl prctice Crdiology 4 6 Psychitry 6 5 Other Group prctice size (%) < Yers since medicl school grdution (%) < U.S. geogrphic region (%) <0.001 Northest Midwest South Pcific West Mountin West 6 6 Urn (%) <0.001 Difference (95% CI) d Medin household income in ZIP Code 44.7 ± ± (-0.54, -0.25) ($1,000) % clims for LIS eneficiries 43.0 ± ± (2.85, 3.23) % clims for MA-PD eneficiries 33.1 ± ± (2.80, 3.15) Proportion of ll 2013 clims (in ny drug (-2.42, -2.20) clss) written for rnded drugs (%) Plus-minus vlues re mens +/-SD. ACE denotes ngiotensin-converting enzyme, ARB ngiotensin-receptor locker, SSRI selective serotonin-reuptke inhiitor, nd SNRI serotonin-norepinephrine reuptke inhiitor. LIS refers to low-income susidy nd MA-PD refers to Medicre Advntge Prt D. Percentges do not dd up to 100% due to missing oservtions. Pyments refer to those conducted etween August 1, 2013 nd Decemer 31 st, 2013 in the Generl ctegory of the Open Pyments dtset, excluding reserch-relted or proprietry pyments. c Reported p-vlues re the result of chi-squre tests of the ssocition etween the ctegoricl vrile nd receipt of ny form of industry pyment. d For continuous vriles, 2-smple t-tests were conducted to test the difference in mens etween physicins who did nd did not receive ny form of industry pyment Americn Medicl Assocition. All rights reserved. Downloded From: on 10/13/2018
5 etle 3. Predictors of Trget Drug Prescriing, Adjusted for Averge Cost per Mel Vrile Rosuvsttin (N = 9,066) Neivolol Olmesrtn (N = 2,066) (N = 7,811) Adjusted Odds Rtios (95% CI) Desvenlfxine (N = 1,644) Dys receiving trget drugsponsored mels (1.02, 1.03) 1.18 (1.16, 1.20) 1.18 (1.17, 1.19) 1.06 (1.01, 1.11) (1.06, 1.07) 1.30 (1.26, 1.33) 1.31 (1.29, 1.33) 1.50 (1.40, 1.59) (1.13, 1.15) 1.45 (1.40, 1.50) 1.50 (1.49, 1.52) 1.32 (1.23, 1.42) Averge cost per mel pyment < $20 $ (1.12, 1.13) 1.11 (1.07, 1.15) 1.02 (1.01, 1.03) 1.05 (0.91, 1.22) Mle Femle 1.05 (1.04, 1.06) 0.93 (0.91, 0.94) 1.01 (1.00, 1.02) 0.76 (0.73, 0.80) Totl volume of clims within the drug clss 1.00 (1.00, 1.00) 0.98 (0.98, 0.98) 1.01 (1.01, 1.01) 0.98 (0.98, 0.99) Specilty Internl Medicine Fmily Medicine nd Generl Prctice 1.03 (1.03, 1.04) 0.99 (0.97, 1.00) 0.91 (0.90, 0.91) 1.04 (1.00, 1.08) Crdiology 1.45 (1.44, 1.46) 1.27 (1.24, 1.29) 0.94 (0.92, 0.96) - Psychitry (2.21, 4.04) Other 1.12 (1.10, 1.13) 1.21 (1.16, 1.27) 0.86 (0.84, 0.89) 1.64 (1.50, 1.80) Numer of memers in group prctice (0.90, 0.91) 0.88 (0.86, 0.89) 0.85 (0.84, 0.86) 0.80 (0.76, 0.84) (0.88, 0.89) 0.93 (0.91, 0.95) 0.86 (0.85, 0.88) 0.97 (0.91, 1.03) (0.87, 0.88) 0.82 (0.80, 0.84) 0.85 (0.84, 0.86) 0.80 (0.76, 0.84) % of prescriptions for rnded drugs < 25 th percentile 0.65 (0.65, 0.66) 0.51 (0.49, 0.52) 0.58 (0.57, 0.60) 0.79 (0.72, 0.86) Within 25 th -75 th percentile 75 th percentile 1.68 (1.67, 1.69) 2.25 (1.91, 2.68) 1.79 (1.78, 1.81) 1.96 (1.88, 2.04) Yers since grdution from med school (1.06, 1.13) 2.25 (1.91, 2.68) 1.10 (1.02, 1.20) 0.99 (0.75, 1.35) (1.09, 1.16) 2.24 (1.90, 2.66) 1.17 (1.09, 1.27) 1.12 (0.84, 1.52) Geogrphic region Northest Midwest 0.93 (0.92, 0.94) 1.48 (1.45, 1.52) 0.73 (0.72, 0.75) 1.52 (1.41, 1.64) South 1.12 (1.11, 1.13) 1.56 (1.53, 1.59) 0.80 (0.80, 0.81) 1.45 (1.35, 1.55) Pcific West 0.79 (0.78, 0.80) 1.38 (1.34, 1.41) 1.11 (1.09, 1.12) 1.95 (1.77, 2.15) Mountin West 0.92 (0.91, 0.93) 1.98 (1.92, 2.05) 0.87 (0.84, 0.89) 0.80 (0.70, 0.91) Popultion Density Rurl Urn 1.09 (1.08, 1.10) 0.96 (0.94, 0.97) 1.27 (1.25, 1.29) 0.99 (0.94, 1.04) Medin Household income in ZIP c Code 0.97 (0.96, 0.97) 0.98 (0.97, 0.98) 0.97 (0.97, 0.98) 0.95 (0.93, 0.97) % Clims for LIS eneficiries 1.00 (1.00, 1.00) 1.00 (1.00, 1.00) 1.00 (1.00, 1.00) 1.01 (1.00, 1.01) % Clims for MA-PD eneficiries 1.00 (1.00, 1.00) 1.00 (1.00, 1.00) 1.00 (1.00, 1.00) 1.00 (1.00, 1.00) This multivrile logistic regression nlysis ws restricted to physicins who received t lest one trget mel, nd djusted for verge cost per mel received (<$20 or $20). Prescription volume ws divided y 100 to produce more meningful odds rtios. c Medin Household Income in ZIP Code ws converted to Z-Score Americn Medicl Assocition. All rights reserved. Downloded From: on 10/13/2018
6 etle 4. Propensity Score Decile-Adjusted Odds Rtios for Prescriing the Trget Drug Vrile Rosuvsttin (N = 111,587) Neivolol (N = 116,355) Olmesrtn (N = 121,318) Desvenlfxine (N = 113,983) Did not receive trget mels Received trget mels 1.19 (1.19, 1.20) 1.79 (1.78, 1.80) 1.74 (1.73, 1.75) 2.30 (2.25, 2.34) Propensity scores were clculted using logistic regression predicting receipt of trget mels. In ddition to propensity score decile, odds rtios were djusted for ll covrites included in the min regression (listed in Tle 3). etle 5. Results of Flsifiction Test: The Effect of Rosuvsttin Mels on Desvenlfxine Prescriing, nd the Effect of Desvenlfxine Mels on Rosuvsttin Prescriing Vrile Sttin Prescriers SSRI/SNRI Prescriers (N = 111,231) (N = 113,192) Dys receiving mels promoting the opposite drug Adjusted OR (95% CI) for prescriing: Rosuvsttin Desvenlfxine (0.98, 1.00) 1.22 (1.20, 1.24) (0.94, 0.98) 1.20 (1.17, 1.23) (0.99, 1.08) 1.12 (1.08, 1.16) (0.95, 1.03) 1.46 (1.40, 1.52) Mle Femle 1.05 (1.04, 1.05) 0.83 (0.83, 0.84) Totl volume of clims within the drug clss 1.01 (1.01, 1.01) 1.00 (1.00, 1.00) Specilty Internl Medicine Fmily Medicine nd Generl Prctice 1.04 (1.03, 1.04) 1.15 (1.14, 1.16) Crdiology 1.63 (1.62, 1.63) - Psychitry (6.68, 6.85) Other 0.92 (0.91, 0.92) 1.08 (1.06, 1.10) Numer of memers in group prctice (0.92, 0.92) 0.91 (0.90, 0.92) (0.92, 0.92) 0.85 (0.84, 0.86) (0.91, 0.91) 0.71 (0.70, 0.72) % of prescriptions for rnded drugs < 25 th percentile 0.67 (0.66, 0.67) 0.48 (0.48, 0.49) Within 25 th -75 th percentile 75 th percentile 1.71 (1.70, 1.71) 1.75 (1.74, 1.77) Yers since grdution from med school (1.04, 1.06) 1.29 (1.23, 1.35) (1.04, 1.06) 1.28 (1.23, 1.34) Geogrphic region Northest Midwest 0.91 (0.91, 0.92) 1.53 (1.51, 1.55) South 1.11 (1.11, 1.11) 1.86 (1.84, 1.88) Pcific West 0.64 (0.64, 0.64) 1.29 (1.27, 1.31) Mountin West 0.87 (0.87, 0.88) 1.41 (1.37, 1.44) Popultion Density Rurl Urn 1.02 (1.02, 1.02) 0.88 (0.88, 0.89) Medin Household income in ZIP Code 0.95 (0.95, 0.95) 0.93 (0.92, 0.93) % Clims for LIS eneficiries 1.00 (1.00, 1.00) 1.00 (1.00, 1.00) % Clims for MA-PD eneficiries 1.00 (1.00, 1.00) 1.00 (1.00, 1.00) The flsifiction test ws limited to, in the left column, physicins who wrote over 20 sttin prescriptions; did not receive ny rosuvsttin pyments; nd did not receive ny desvenlfxine pyments other thn mels. The right column ws limited to physicins who wrote over 20 SSRI/SNRI prescriptions; did not receive ny desvenlfxine pyments; nd did not receive ny rosuvsttin pyments other thn mels. Prescription volume ws divided y 100 to produce 2016 Americn Medicl Assocition. All rights reserved. Downloded From: on 10/13/2018
7 more meningful odds rtios. Medin Household Income in ZIP Code ws converted to Z-Score. etle 6. Predictors of Trget Drug Prescriing, with Low-Volume Prescriers Excluded Vrile Rosuvsttin (N = 81,097) Neivolol (N = 66,016) Olmesrtn (N = 82,321) Desvenlfxine (N = 54,788) Adjusted Odds Rtios (95% CI) Dys receiving trget drugsponsored mels (1.17, 1.17) 1.68 (1.67, 1.70) 1.50 (1.49, 1.51) 2.05 (2.00, 2.10) (1.18, 1.20) 1.82 (1.79, 1.85) 1.77 (1.75, 1.78) 2.18 (2.09, 2.28) (1.23, 1.25) 2.07 (2.01, 2.12) 1.96 (1.93, 1.98) 3.05 (2.87, 3.24) (1.33, 1.36) 2.34 (2.26, 2.42) 2.22 (2.20, 2.24) 2.59 (2.42, 2.75) Mle Femle 1.05 (1.05, 1.06) 0.90 (0.89, 0.90) 1.07 (1.06, 1.07) 0.84 (0.83, 0.85) Totl volume of clims within the drug clss 1.00 (1.00, 1.00) 1.00 (1.00, 1.00) 1.02 (1.02, 1.02) 1.00 (1.00, 1.00) Specilty Internl Medicine Fmily Medicine nd Generl Prctice 1.03 (1.03, 1.04) 1.07 (1.06, 1.07) 0.97 (0.97, 0.97) 1.15 (1.14, 1.16) Crdiology 1.66 (1.65, 1.66) 1.34 (1.33, 1.34) 0.97 (0.96, 0.97) - Psychitry (6.48, 6.64) Other 0.97 (0.96, 0.97) 1.01 (1.00, 1.02) 0.80 (0.80, 0.81) 1.25 (1.22, 1.27) Numer of memers in group prctice (0.92, 0.92) 0.96 (0.95, 0.96) 0.88 (0.87, 0.88) 0.91 (0.90, 0.92) (0.92, 0.92) 0.88 (0.87, 0.88) 0.84 (0.83, 0.84) 0.87 (0.86, 0.88) (0.92, 0.92) 0.76 (0.76, 0.76) 0.79 (0.79, 0.80) 0.74 (0.73, 0.75) % of prescriptions for rnded drugs < 25 th percentile 0.70 (0.69, 0.70) 0.47 (0.47, 0.47) 0.53 (0.53, 0.54) 0.49 (0.49, 0.50) Within 25 th -75 th percentile 75 th percentile 1.64 (1.64, 1.64) 2.26 (2.25, 2.27) 1.92 (1.91, 1.93) 1.79 (1.78, 1.81) Yers since grdution from med school (0.97, 0.99) 0.99 (0.97, 1.02) 1.18 (1.14, 1.21) 1.15 (1.09, 1.21) (0.97, 0.99) 0.94 (0.91, 0.97) 1.24 (1.20, 1.27) 1.15 (1.09, 1.21) Geogrphic region Northest Midwest 0.91 (0.91, 0.91) 1.53 (1.52, 1.54) 0.72 (0.72, 0.73) 1.49 (1.46, 1.51) South 1.10 (1.09, 1.10) 1.62 (1.61, 1.63) 0.85 (0.85, 0.86) 1.73 (1.71, 1.76) Pcific West 0.65 (0.65, 0.65) 1.23 (1.22, 1.24) 1.05 (1.04, 1.06) 1.24 (1.22, 1.27) Mountin West 0.87 (0.87, 0.88) 1.68 (1.66, 1.70) 0.93 (0.92, 0.94) 1.25 (1.22, 1.29) Popultion Density Rurl Urn 1.03 (1.02, 1.03) 0.97 (0.97, 0.97) 1.20 (1.19, 1.21) 0.92 (0.91, 0.93) Medin Household income in ZIP Code 0.96 (0.95, 0.96) 0.98 (0.97, 0.98) 0.97 (0.97, 0.98) 0.93 (0.92, 0.93) % Clims for LIS eneficiries 1.00 (1.00, 1.00) 1.00 (1.00, 1.00) 0.99 (0.99, 0.99) 1.00 (1.00, 1.00) % Clims for MA-PD eneficiries 1.00 (1.00, 1.00) 1.00 (1.00, 1.00) 0.99 (0.99, 0.99) 1.00 (1.00, 1.00) Prescription volume ws divided y 100 to produce more meningful odds rtios. Medin Household Income in ZIP Code ws converted to Z-Score. Physicins who prescried fewer thn 200 prescriptions were excluded from the nlysis Americn Medicl Assocition. All rights reserved. Downloded From: on 10/13/2018
8 etle 7. Predictors of Trget Drug Prescriing, with Clim Count Stndrdized to 30-Dy Supplies Vrile Rosuvsttin (N = 111,588) Neivolol (N = 116,356) Olmesrtn (N = 121,319) Desvenlfxine (N = 113,984) Adjusted Odds Rtios (95% CI) Dys receiving trget drugsponsored mels (1.17, 1.17) 1.73 (1.72, 1.74) 1.53 (1.52, 1.54) 2.32 (2.28, 2.37) (1.18, 1.19) 1.92 (1.90, 1.95) 1.76 (1.75, 1.77) 2.47 (2.38, 2.57) (1.22, 1.24) 2.17 (2.12, 2.22) 1.96 (1.94, 1.99) 3.56 (3.37, 3.76) (1.34, 1.36) 2.72 (2.64, 2.79) 2.29 (2.27, 2.31) 2.71 (2.55, 2.87) Mle Femle 1.03 (1.03, 1.03) 0.86 (0.86, 0.86) 1.03 (1.03, 1.04) 0.83 (0.82, 0.84) Totl volume of clims within the drug clss 1.01 (1.01, 1.01) 1.01 (1.01, 1.01) 1.03 (1.03, 1.03) 1.00 (1.00, 1.00) Specilty Internl Medicine Fmily Medicine nd Generl Prctice 1.03 (1.03, 1.03) 1.07 (1.07, 1.08) 0.95 (0.95, 0.96) 1.15 (1.13, 1.16) Crdiology 1.67 (1.66, 1.67) 1.29 (1.29, 1.30) 0.90 (0.89, 0.90) - Psychitry (7.45, 7.62) Other 0.94 (0.93, 0.94) 0.94 (0.94, 0.95) 0.72 (0.71, 0.72) 1.13 (1.11, 1.15) Numer of memers in group prctice (0.92, 0.92) 0.94 (0.94, 0.94) 0.87 (0.87, 0.88) 0.88 (0.87, 0.89) (0.92, 0.93) 0.85 (0.84, 0.85) 0.85 (0.84, 0.85) 0.82 (0.81, 0.83) (0.91, 0.91) 0.71 (0.71, 0.71) 0.78 (0.78, 0.79) 0.66 (0.65, 0.67) % of prescriptions for rnded drugs < 25 th percentile 0.68 (0.67, 0.68) 0.43 (0.43, 0.44) 0.51 (0.51, 0.51) 0.49 (0.48, 0.50) Within 25 th -75 th percentile 75 th percentile 1.66 (1.66, 1.67) 2.34 (2.34, 2.35) 1.92 (1.91, 1.92) 1.79 (1.77, 1.80) Yers since grdution from med school (1.04, 1.06) 1.23 (1.20, 1.25) 1.42 (1.39, 1.45) 1.25 (1.20, 1.31) (1.03, 1.05) 1.17 (1.15, 1.19) 1.53 (1.49, 1.56) 1.26 (1.21, 1.32) Geogrphic region Northest Midwest 0.89 (0.89, 0.89) 1.47 (1.46, 1.47) 0.69 (0.69, 0.70) 1.44 (1.42, 1.46) South 1.08 (1.08, 1.08) 1.62 (1.61, 1.63) 0.84 (0.84, 0.85) 1.81 (1.79, 1.83) Pcific West 0.60 (0.59, 0.60) 1.12 (1.11, 1.12) 0.98 (0.98, 0.99) 1.26 (1.24, 1.28) Mountin West 0.86 (0.86, 0.86) 1.71 (1.69, 1.72) 0.90 (0.89, 0.91) 1.33 (1.30, 1.36) Popultion Density Rurl Urn 1.03 (1.03, 1.04) 0.97 (0.96, 0.97) 1.21 (1.21, 1.22) 0.90 (0.89, 0.90) Medin Household income in ZIP Code 0.96 (0.96, 0.96) 0.99 (0.99, 0.99) 0.98 (0.98, 0.99) 0.92 (0.91, 0.92) % Clims for LIS eneficiries 1.00 (1.00, 1.00) 1.00 (1.00, 1.00) 0.99 (0.99, 0.99) 1.00 (1.00, 1.00) % Clims for MA-PD eneficiries 0.99 (0.99, 0.99) 1.00 (1.00, 1.00) 0.99 (0.99, 0.99) 1.00 (1.00, 1.00) Prescription volume ws divided y 100 to produce more meningful odds rtios. Medin Household Income in ZIP Code ws converted to Z-Score Americn Medicl Assocition. All rights reserved. Downloded From: on 10/13/2018
9 etle 8. Predictors of Rosuvsttin Prescriing s Percentge of High-Intensity Sttin Prescriptions Vrile Rosuvsttin (N = 111,588) Adjusted Odds Rtio (95% CI) Dys receiving rosuvsttin-sponsored mels (1.13, 1.14) (1.13, 1.14) (1.17, 1.19) (1.20, 1.23) Mle Femle 1.07 (1.07, 1.07) Totl volume of clims within the drug clss 1.00 (1.00, 1.00) Specilty Internl Medicine Fmily Medicine nd Generl Prctice 1.06 (1.06, 1.06) Crdiology 1.22 (1.22, 1.23) Psychitry - Other 0.93 (0.93, 0.94) Numer of memers in group prctice (0.93, 0.93) (0.92, 0.92) (0.90, 0.91) % of prescriptions for rnded drugs < 25 th percentile 0.82 (0.82, 0.82) Within 25 th -75 th percentile 75 th percentile 1.34 (1.33, 1.34) Yers since grdution from med school (1.02, 1.04) (1.04, 1.06) Geogrphic region Northest Midwest 0.99 (0.99, 1.00) South 1.19 (1.18, 1.19) Pcific West 0.68 (0.68, 0.68) Mountin West 1.01 (1.01, 1.02) Popultion Density Rurl Urn 0.97 (0.96, 0.97) Medin Household income in ZIP Code c 0.95 (0.95, 0.96) % Clims for LIS eneficiries 1.00 (1.00, 1.00) % Clims for MA-PD eneficiries 1.00 (1.00, 1.00) High-intensity sttins refers to rosuvsttin nd torvsttin. Prescription volume ws divided y 100 to produce more meningful odds rtios. c Medin Household Income in ZIP Code ws converted to Z-Score Americn Medicl Assocition. All rights reserved. Downloded From: on 10/13/2018
Supplementary Online Content
Supplementry Online Content Rieckmnn N, Kronish IM, Shpiro PA, Whng W, Dvidson KW. Serotonin reuptke inhibitor use, depression, nd long-term outcomes fter n cute coronry : prospective cohort study. JAMA
More informationSupplementary Online Content
Supplementry Online Content Zulmn DM, Pl Chee C, Ezeji-Okoye SC, et l. Effect of n intensive outptient progrm to ugment primry cre for high-need Veterns Affirs ptients: rndomized clinicl tril. JAMA Intern
More informationReceiving family physician s advice and the stages of change in smoking cessation among Arab minority men in Israel
Fmily Prctice, 2016, Vol. 33, No. 6, 626 632 doi:10.1093/fmpr/cmw090 Advnce Access puliction 2 Septemer 2016 Epidemiology Receiving fmily physicin s dvice nd the stges of chnge in smoking cesstion mong
More informationMetabolic syndrome (MetS) is defined by a group
ORIGINAL ARTICLE Prevlence of Metolic Syndrome in Lrge Integrted Helth Cre System in North Crolin Rohn Mhleshwrkr, Yhenneko J. Tylor, Melnie D. Spencer, Svet Mohnn ckground Metolic syndrome (MetS) is cluster
More informationStatin Use and Its Association with Essential Tremor and Parkinson s Disease
Originl Pper Received: April 24, 2016 Accepted: My 6, 2016 Published online: June 16, 2016 Sttin Use nd Its Assocition with Essentil Tremor nd Prkinson s Disese Sherif Y. Shlby Eln D. Louis c Deprtment
More informationThis supplementary material has been provided by the authors to give readers additional information about their work.
Supplementry Online Content Qto DM, Ozenerger K, Olfson M. Prevlence of prescription medictions with depression s potentil dverse effect mong dults in the United Sttes. JAMA. doi:10.1001/jm.2018.6741 etle
More informationRxBlue 2010 ST Criteria
RxBlue 2010 ST Criteria ANTIDEPRESSANTS - SARAFEM... 10 FLUOXETINE HCL... 10 SARAFEM... 10 SELFEMRA... 10 ANTIDEPRESSANTS- SSRI, SNRI... 11 CELEXA... 11 CITALOPRAM... 11 CYMBALTA... 11 EFFEXOR XR... 11
More informationPNEUMOVAX 23 is recommended by the CDC for all your appropriate adult patients at increased risk for pneumococcal disease 1,2 :
PNEUMOVAX 23 is recommended y the CDC for ll your pproprite dult ptients t incresed risk for pneumococcl disese 1,2 : Adults ged
More informationClinical Study Report Synopsis Drug Substance Naloxegol Study Code D3820C00018 Edition Number 1 Date 01 February 2013 EudraCT Number
EudrCT Number 2012-001531-31 A Phse I, Rndomised, Open-lbel, 3-wy Cross-over Study in Helthy Volunteers to Demonstrte the Bioequivlence of the Nloxegol 25 mg Commercil nd Phse III Formultions nd to Assess
More informationInvasive Pneumococcal Disease Quarterly Report July September 2018
Invsive Pneumococcl Disese Qurterly Report July Septemer Introduction Since 17 Octoer 2008, invsive pneumococcl disese (IPD) hs een notifile to the locl Medicl Officer of Helth under the Helth Act 1956.
More informationCommunity. Profile Powell County. Public Health and Safety Division
Community Helth Profile 2015 Powell County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationCommunity. Profile Big Horn County. Public Health and Safety Division
Community Helth Profile 2015 Big Horn County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Yellowstone County. Public Health and Safety Division
Community Helth Profile 2015 Yellowstone County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Lewis & Clark County. Public Health and Safety Division
Community Helth Profile 2015 Lewis & Clrk County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Missoula County. Public Health and Safety Division
Community Helth Profile 2015 Missoul County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationCommunity. Profile Anaconda- Deer Lodge County. Public Health and Safety Division
Community Helth Profile 2015 Ancond- Deer Lodge County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12
More informationCheckMate 153: Randomized Results of Continuous vs 1-Year Fixed-Duration Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer
CheckMte 53: Rndomized Results of Continuous vs -Yer Fixed-Durtion Nivolumb in Ptients With Advnced Non-Smll Cell Lung Cncer Abstrct 297O Spigel DR, McCleod M, Hussein MA, Wterhouse DM, Einhorn L, Horn
More informationSYNOPSIS Final Abbreviated Clinical Study Report for Study CA ABBREVIATED REPORT
Finl Arevited Clinicl Study Report Nme of Sponsor/Compny: Bristol-Myers Squi Ipilimum Individul Study Tle Referring to the Dossier (For Ntionl Authority Use Only) Nme of Finished Product: Yervoy Nme of
More informationAssessment of Depression in Multiple Sclerosis. Validity of Including Somatic Items on the Beck Depression Inventory II
Assessment of Depression in Multiple Sclerosis Vlidity of Including Somtic Items on the Beck Depression Inventory II Peggy Crwford, PhD; Noh J. Webster, MA Signs nd symptoms of multiple sclerosis (MS)
More informationRisks for All-Cause Mortality: Stratified by Age, Estimated Glomerular Filtration Rate and Albuminuria
Clinicl Prctice: Mini-Review Received: My 20, 2016 Accepted fter revision: December 14, 2016 Published online: Jnury 27, 2017 Risks for All-Cuse Mortlity: Strtified by Age, Estimted Glomerulr Filtrtion
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES
Generic Brand HICL GCN Exception/Other BUPROPION HCL WELLBUTRIN, 01653 WELLBUTRIN SR, WELLBUTRIN XL BUPROPION HBR APLENZIN 17050 16996 26198 CITALOPRAM CELEXA 10321 GPID 16344 HYDROBROMIDE DESVENLAFAXINE
More informationTrends in antihypertensive and lipidlowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
ORIGINAL ARTICLE Trends in ntihypertensive nd lipidlowering therpy in subjects with type II dibetes: clinicl effectiveness or clinicl discretion? MC Gulliford, J Chrlton nd R Ltinovic Deprtment of Public
More informationInvasive Pneumococcal Disease Quarterly Report. July September 2017
Invsive Pneumococcl Disese Qurterly Report July September 2017 Prepred s prt of Ministry of Helth contrct for scientific services by Rebekh Roos Helen Heffernn October 2017 Acknowledgements This report
More informationXII. HIV/AIDS. Knowledge about HIV Transmission and Misconceptions about HIV
XII. HIV/AIDS Knowledge bout HIV Trnsmission nd Misconceptions bout HIV One of the most importnt prerequisites for reducing the rte of HIV infection is ccurte knowledge of how HIV is trnsmitted nd strtegies
More informationImpact of Pharmacist Intervention on Diabetes Patients in an Ambulatory Setting
Impct of Phrmcist Intervention on Dibetes Ptients in n Ambultory Setting Julie Stding, PhrmD, CDE, Jmie Herrmnn, PhrmD, Ryn Wlters, MS, Chris Destche, PhrmD, nd Aln Chock, PhrmD Dibetes is the seventh-leding
More informationEfficacy of Pembrolizumab in Patients With Advanced Melanoma With Stable Brain Metastases at Baseline: A Pooled Retrospective Analysis
Efficcy of Pembrolizumb in Ptients With Advnced Melnom With Stble Brin Metstses t Bseline: A Pooled Retrospective Anlysis Abstrct 1248PD Hmid O, Ribs A, Dud A, Butler MO, Crlino MS, Hwu WJ, Long GV, Ancell
More informationCommunity. Profile Carter County. Public Health and Safety Division
Community Helth Profile 2015 Crter County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationMetabolic Syndrome and Health-related Quality of Life in Obese Individuals Seeking Weight Reduction
Metbolic Syndrome nd Helth-relted Qulity of Life in Obese Individuls Seeking Weight Reduction Adm Gilden Tsi 1, Thoms A. Wdden 1, Dvid B. Srwer 1, Robert I. Berkowitz 1, Leslie G. Womble 1, Louise A. Hesson
More informationCardiac Medications At A Glance
Cardiac Medications At A Glance 1) Anticoagulants (Also known as Blood Thinners.) Dalteparin (Fragmin), Danaparoid (Orgaran) Enoxaparin (Lovenox) Heparin (various) Tinzaparin (Innohep) Warfarin (Coumadin)
More informationMental health symptoms and patient-reported diabetes symptom burden: implications for medication regimen changes
Fmily Prctice, 2015, Vol. 32, No. 3, 317 322 doi:10.1093/fmpr/cmv014 Advnce Access publiction 5 April 2015 Helth Service Reserch Mentl helth symptoms nd ptient-reported dibetes symptom burden: implictions
More informationEthnic Disparities in Stroke Recognition in Individuals with Prior Stroke
Reserch Articles Ethnic Disprities in Stroke Recognition in Individuls with Prior Stroke Chrles Ellis, PhD Leonrd E. Egede, MD, MS,c SYNOPSIS Ojective. Studies of stroke wreness suggest tht knowledge of
More informationMedicare Shared Savings Program Accountable Care Organization (ACO) Measures Deep Dive Series
Medicare Shared Savings Program Accountable Care Organization (ACO) Measures Deep Dive Series At Risk Population: Measure 33 Coronary Artery Disease (CAD-7): Angiotensin-Converting Enzyme (ACE) Inhibitor
More informationThe RUTHERFORD-2 trial in heterozygous FH: Results and implications
The RUTHERFORD-2 tril in heterozygous FH: Results nd implictions Slide deck kindly supplied s n eductionl resource by Professor Derick Rl MD PhD Crbohydrte & Lipid Metbolism Reserch Unit University of
More informationIn 2006, the prevalence of bipolar
With Bipolr Disorder Annette M. Mtthews, MD; Vness B. Wilson, BA; Suznne H. Mitchell, PhD; nd Peter Huser, MD This study of smoking ehviors nd smoking chrcteristics in veterns with ipolr disorder contriutes
More informationkey words: chronic obstructive pulmonary disease, beta agonists, Medicare, health care costs, health care utilization
reserch report Helth Cre Use nd Costs Among Medicre Ptients With Chronic Obstructive Pulmonry Disese Treted With Short-Acting Bet Agonists or Long-Acting Bet Agonists Flvi Ejzykowicz, PhD; 1 Vmsi K Bollu,
More informationPrime Enrollees Consumer Watch NHC Patuxent River FY 2016 Defense Health Cost Assessment & Program Evaluation
Prime Enrollees Consumer Wtch NHC Ptuxent River 16 Defense Helth Cost Assessment & Progrm Evlution NHC Ptuxent River: Smple size-1,457 Response rte-1.2% Source: Helth Cre Survey of DoD Beneficiries Inside
More informationIn the treatment of cardiovascular disease (CVD), national
n report n Beyond LDL Cholesterol: The Role of Elevted Triglycerides nd Low HDL Cholesterol in Residul CVD Risk Remining After Sttin Therpy Peter Algon Jr, MD, FACC In the tretment of crdiovsculr disese
More informationUrinary Tract Infection in Men
C H A P T E R 1 9 Urinry Trct Infection in Men Toms L. Griebling, MD Associte Professor & Vice Chir of Urology University of Knss Knss City, Knss Contents INTRODUCTION........................................623
More informationFactors influencing help seeking in mentally distressed young adults: a cross-sectional survey
L Biddle, D Gunnell, D Shrp nd J L Donovn Fctors influencing help seeking in mentlly distressed young dults: cross-sectionl survey Lucy Biddle, Dvid Gunnell, Debbie Shrp nd Jenny L Donovn SUMMARY Bckground:
More informationSummary: American Red Cross-Northeast Region, Dedham, MA; 11 Department of Pathology, University of New Mexico, Albuquerque, NM; 12
(2000) 25, 385 393 2000 Mcmilln Pulishers Ltd All rights reserved 0268 3369/00 $15.00 www.nture.com/mt The extent of HLA clss II llele level disprity in unrelted one mrrow trnsplnttion: nlysis of 1259
More informationUsing Paclobutrazol to Suppress Inflorescence Height of Potted Phalaenopsis Orchids
Using Pcloutrzol to Suppress Inflorescence Height of Potted Phlenopsis Orchids A REPORT SUBMITTED TO FINE AMERICAS Linsey Newton nd Erik Runkle Deprtment of Horticulture Spring 28 Using Pcloutrzol to Suppress
More informationAdapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017
Insert Logo or Org Name Here Primary Care Medical Directive for Hypertension Management Adapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017 Title:
More informationDiabetes affects 29 million Americans, imposing a substantial
CLINICAL Comprtive Effectiveness nd Costs of Insulin Pump Therpy for Dibetes Ronld T. Ackermnn, MD, MPH; Amish Wlli, MD, MS; Rymond Kng, MA; Andrew Cooper, MPH; Theodore A. Prospect, FSA, MAAA; Lewis G.
More informationRoughage Type & Level & Grain Processing Interactions with Distiller s s Grains Diets. Matt May High Plains Bio Fuels Co-Product Nutrition Conference
Roughge Type & Level & Grin Processing Interctions with Distiller s s Grins Diets Mtt My High Plins Bio Fuels Co-Product Nutrition Conference Why do we flke grin? Stem-flked corn (SFC) vs. dry-rolled rolled
More informationBilling and Coding Guide. Hospital Outpatient Department
illing nd oding Guide Hospitl Outptient Deprtment overge, coding, nd pyment in the hospitl outptient deprtment ONPTTRO (ptisirn) received US Food nd Drug dministrtion (FD) pprovl on 10 ug 2018, nd is indicted
More informationSupplementary figure 1
Supplementry figure 1 Dy 8 post LCMV infection Vsculr Assoc. Prenchym Dy 3 post LCMV infection 1 5 6.7.29 1 4 1 3 1 2 88.9 4.16 1 2 1 3 1 4 1 5 1 5 1.59 5.97 1 4 1 3 1 2 21.4 71 1 2 1 3 1 4 1 5 1 5.59.22
More informationPDF created with pdffactory trial version
We are using more prescription drugs than ever before to manage health conditions and prevent problems. And those drugs are more expensive than ever before. In 2003, prescription drug costs in the United
More informationAnnual Review of Antihypertensives - Fiscal Year 2009
Annual Review of Antihypertensives - Fiscal Year 2009 Oklahoma HealthCare Authority April 2010 Current Prior Authorization Criteria There are 7 categories of antihypertensive medications currently included
More informationPresented at the 75 th Annual Meeting of the American Academy of Dermatology, Orlando, FL, March 3-7, 2017 METHODS INTRODUCTION OBJECTIVE
Seven-Yer Interim Results from the ESPRIT 10-Yer Postmrketing Surveillnce Registry of Adlimumb for Moderte to Severe Psorisis Frncisco Kerdel, 1 Aln Menter, 2 Jshin J. Wu, 3 Mreike Bereswill, 4 Dilek Arikn,
More informationInput from external experts and manufacturer on the 2 nd draft project plan Stool DNA testing for early detection of colorectal cancer
Input externl experts nd mnufcturer on the 2 nd drft project pln Stool DNA testing for erly detection of colorectl cncer (Project ID:OTJA10) All s nd uthor s replies on the 2nd drft project pln Stool DNA
More informationEVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1
Swine Dy 2001 Contents EVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1 C. W. Hstd, S. S. Dritz 2, J. L. Nelssen, M. D. Tokch, nd R. D. Goodbnd Summry Two trils were
More informationMeat and Food Safety. B.A. Crow, M.E. Dikeman, L.C. Hollis, R.A. Phebus, A.N. Ray, T.A. Houser, and J.P. Grobbel
Met nd Food Sfety Needle-Free Injection Enhncement of Beef Strip Loins with Phosphte nd Slt Hs Potentil to Improve Yield, Tenderness, nd Juiciness ut Hrm Texture nd Flvor B.A. Crow, M.E. Dikemn, L.C. Hollis,
More informationUrinary Tract Infection in Women
C H A P T E R 1 8 Urinry Trct Infection in Women Toms L. Griebling, MD Associte Professor & Vice Chir of Urology University of Knss Knss City, Knss Contents INTRODUCTION........................................589
More informationBlood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study
originl rticle http://www.kidney-interntionl.org & 202 Interntionl Society of Nephrology Blood pressure levels nd mortlity risk mong hemodilysis ptients in the Dilysis Outcomes nd Prctice Ptterns Study
More informationAppendix J Environmental Justice Populations
Appendix J Environmentl Justice s [This pge intentionlly left blnk] Tble of Contents REFERENCES...J-2 Pge LIST OF TABLES Pge Tble J-1: Demogrphic Overview of Bruinsburg Site Project Are... J-3 Tble J-2:
More informationSample content. Australian Medicines Handbook Pty Ltd
.3.3 ACE inhibitors.3.3 ACE inhibitors See lso p 237, Acute coronry syndromes p 320, p 252 Also known s ngiotensin converting enzyme inhibitors. Cptopril p 22 Enlpril p 22 Fosinopril p 22 Lisinopril p
More informationSUPPLEMENTARY INFORMATION
doi:1.138/nture17 Men tumour dimeter (mm) 2 Rg2-/- 2 1 2 2 1 Control IgG!-CD8!-CD4 1 2 3 1 2 3 c Men tumour dimeter (mm) 2 2 1 d Ifnr1-/- Rg2-/- 2 2 1 Ifngr1-/- d42m1!ic 1 2 3 Dys post trnsplnt 1 2 3 Supplementry
More informationRelationship Between Hospital Performance on a Patient Satisfaction Survey and Surgical Quality
Reserch Originl Investigtion Reltionship Between Hospitl Performnce on Ptient Stisfction Survey nd Surgicl Qulity Greg D. Scks, MD, MPH; Elise H. Lwson, MD, MSHS; Aron J. Dwes, MD; Mrci M. Russell, MD;
More informationEffect of Preoperative Intravenous Methocarbamol and Intravenous Acetaminophen on Opioid Use After Primary Total Hip and Knee Replacement
Feture Article Effect of Preopertive Intrvenous Methocrbmol nd Intrvenous Acetminophen on Opioid Use After Primry Totl Hip nd Knee Replcement THOMAS D. LOOKE, MD, PHD; CAMERON T. KLUTH, MBA bstrct Between
More informationProducts for weaners Benzoic acid or the combination of lactic acid and formic acid
Products for weners Benzoic cid or the comintion of lctic cid nd formic cid Tril report no.: 490 Novemer, 000 Hnne Mrio, Lrs Egelund Olsen, Bent Borg Jensen 1 nd Nuri Miquel 1 The Ntionl Committee for
More informationRecent advances in cryopreservation od salmonid fish semen. Andrzej Ciereszko
Recent dvnces in cryopreservtion od slmonid fish semen Andrzej Ciereszko Institute of Animl Reproduction nd Food Reserch, Polish Acdemy of Sciences in Olsztyn, Polnd Justifiction for the studies Poor performnce
More informationHealth-Related Quality of Life and Symptoms of Depression in Extremely Obese Persons Seeking Bariatric Surgery
Oesity Surgery, 15, 3-39 Helth-Relted Qulity of Life nd Symptoms of Depression in Extremely Oese Persons Seeking Britric Surgery Anthony N. Frictore, PhD; Thoms A. Wdden, PhD; Dvid B. Srwer, PhD; Myles
More informationRegression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study
(2004) 18, 403 409 & 2004 Nture Pulishing Group All rights reserved 0950-9240/04 $30.00 www.nture.com/jhh ORIGINAL ARTICLE Regression of electrocrdiogrphic left ventriculr hypertrophy predicts regression
More informationEpilepsy & Behavior 20 (2011) Contents lists available at ScienceDirect. Epilepsy & Behavior. journal homepage:
Epilepsy & Behvior 20 (2011) 52 56 Contents lists vilble t ScienceDirect Epilepsy & Behvior journl homepge: www.elsevier.com/locte/yebeh Detecting helth disprities mong Cucsins nd Africn-Americns with
More informationEFFECT OF DIETARY ENZYME ON PERFORMANCE OF WEANLING PIGS
EFFECT OF DIETARY ENZYME ON PERFORMANCE OF WEANLING PIGS Finl report sumitted to Dniso Animl Nutrition E. vn Heugten nd B. Frederik North Crolin Stte University, Deprtment of Animl Siene Summry The urrent
More informationTHE EVALUATION OF DEHULLED CANOLA MEAL IN THE DIETS OF GROWING AND FINISHING PIGS
THE EVALUATION OF DEHULLED CANOLA MEAL IN THE DIETS OF GROWING AND FINISHING PIGS THE EVALUATION OF DEHULLED CANOLA MEAL IN THE DIETS OF GROWING AND FINISHING PIGS John F. Ptience nd Doug Gillis SUMMARY
More informationPatient Survival After Surgical Treatment of Rectal Cancer
Originl Article Ptient Survivl After Surgicl Tretment of Rectl Cncer Impct of Surgeon nd Hospitl Chrcteristics Dvid A. Etzioni, MD, MSHS 1,2 ; Toni M. Young-Fdok, MD, MS 1 ; Robert R. Cim, MD, MA 2,3 ;
More informationHIV Surveillance in Women. National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention
HIV Surveillnce in Women Ntionl Center for HIV/AIDS, Virl Heptitis, STD & TB Prevention Division of HIV/AIDS Prevention Dignoses of HIV Infection mong Adult nd Adolescent Femles, by Rce/Ethnicity, 2006
More informationEffect of kazunoko lipid on the concentrations of plasma glucose and lipids and liver lipids in mice
Effect of kzunoko lipid on the concentrtions of plsm glucose nd lipids nd liver lipids in mice Ntionl Food Reserch Institute Tomoyuki Higuchi, Nouy Shiri nd Hirmitsu Suzuki INTRODUCTION Kzunoko, which
More informationReports of cases of AIDS, HIV infection, and HIV/AIDS 1
Reports of cses of AIDS, HIV infection, nd HIV/AIDS 1 The HIV/AIDS Surveillnce Report is published nnully by the Division of HIV/AIDS Prevention Surveillnce nd Epidemiology, Ntionl Center for HIV, STD,
More informationLifetime and 12-Month Prevalence of Psychiatric Disorders in 8,169 Male Vietnam War Era Veterans
MILITARY MEDICINE, 169, 11:896, 2004 Lifetime nd 12-Month Prevlence of Psychitric Disorders in 8,169 Mle Vietnm Wr Er Veterns Gurntor: Seth A. Eisen, MD Contributors: Seth A. Eisen, MD* ; Kristin H. Griffith,
More informationIncreased Antidepressant Drug Exposure in Psoriasis Patients: A Longitudinal Population-based Cohort Study
Act Derm Venereol 2013; 93: 544 550 CLINICAL REPORT Incresed Antidepressnt Drug Exposure in Psorisis Ptients: A Longitudinl Popultion-sed Cohort Study Emmili A. Dowltshhi 1, Mrlies Wkkee 1, Ronld M. C.
More information8/19/2016. No Conflicts. I struggled with everything cardiac in nursing school.
Cindy Weston, DNP, RN, CCRN, CNS CC, FNP BC Assistant Professor, Texas A&M Health Science Center College of Nursing Describe and define epidemiology and pathophysiology of hypertension Differentiate JNC8
More informationLisinopril 20 converting to losartan
Search Lisinopril 20 converting to losartan Stop wasting your time with unanswered searches. lisinopril 40 mg to losartan conversion,cannot Find low price Best. Winds SSW at 10 to 20. Lisinopril 20 to
More informationLiving with Congestive Heart Failure: A Guide to a Healthy Heart
Living with Congestive Heart Failure: A Guide to a Healthy Heart Things to Know, Before You Go Dear Patient/Caregiver These are the things you NEED TO KNOW, BEFORE YOU GO. It is very important that you
More informationManagement of Localized Kidney Cancer: Calculating Cancer-specific Mortality and Competing Risks of Death for Surgery and Nonsurgical Management
EUROPEAN UROLOGY 6 (14) 2 241 ville t www.sciencedirect.com journl homepge: www.europenurology.com Kidney Cncer Mngement of Loclized Kidney Cncer: Clculting Cncer-specific Mortlity nd Competing Risks of
More informationLONG TERM CARE MEDICATIONS MANAGEMENT INITIATIVE JULY Prepared by the Long-Term Care Medications Management Working Group
LONG TERM CARE MEDICATIONS MANAGEMENT INITIATIVE JULY 2016 (last updated July 28, 2016) Prepared by the Long-Term Care Medications Management Working Group Drug Classes for Consideration Angiotensin Converting
More informationUtilization of dental services in Southern China. Lo, ECM; Lin, HC; Wang, ZJ; Wong, MCM; Schwarz, E
Title Utiliztion of dentl services in Southern Chin Author(s) Lo, ECM; Lin, HC; Wng, ZJ; Wong, MCM; Schwrz, E Cittion Journl Of Dentl Reserch, 2001, v. 80 n. 5, p. 1471-1474 Issued Dte 2001 URL http://hdl.hndle.net/10722/53200
More information12.5mg, 25mg, 50mg. 25mg, 50mg. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg. -- $2.81 Acetazolamide (IR, 125mg, 250mg, 500mg (ER)
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Blood Pressure P&T DATE: 5/9/2017 THERAPEUTIC CLASS: Cardiovascular Disorders REVIEW HISTORY: 9/15, 2/13, 2/08, 5/07 LOB
More informationAccuracy of reporting food energy intake: influence of ethnicity and body weight status in South African women
Accurcy of reporting food energy intke: influence of ethnicity nd ody weight sttus in South Africn women Mchiz ZJ, PhD Goedecke JH, PhD Lmert EV, PhD Knowledge Systems, Nutrition Unit, Humn Science Reserch
More informationEffectiveness of Belt Positioning Booster Seats: An Updated Assessment
ARTICLES Effectiveness of Belt Positioning Booster Sets: An Updted Assessment AUTHORS: Kristy B. Arbogst, PhD, Jessic S. Jermkin, DSc, Michel J. Klln, MS, b nd Dennis R. Durbin, MD, MSCE,b Center for Injury
More informationDetecting Undiagnosed Type 2 Diabetes: Family History as a Risk Factor and Screening Tool. Rodolfo Valdez, Ph.D.
Journl of Dietes Science nd Technology Volume 3, Issue 4, July 2009 Dietes Technology Society SYMPOSIUM Detecting Undignosed Type 2 Dietes: Fmily History s Risk Fctor nd Screening Tool Rodolfo, Ph.D. Astrct
More informationHow Do Emergency Physicians Interpret Prescription Narcotic History When Assessing Patients Presenting to the Emergency Department with Pain?
credits ville for this rticle see pge 80. How Do Emergency Physicins Interpret Prescription Nrcotic History When Assessing Ptients Presenting to the Emergency Deprtment with Pin? y A Grover, MD; Gus M
More informationPotential for Interactions Between Dietary Supplements and Prescription Medications a
CLINICAL RESEARCH STUDY Potentil for Interctions Between Dietry Supplements nd Prescription Medictions Amit Sood, MD, MSc, Rich Sood, MD, b Frncis J. Brinker, ND, Rvneet Mnn, MBBS, c Lur L. Loehrer, Dietlind
More informationHeart Failure in Outpatients: Comorbidities and Management by Different Specialists. The EPISERVE Study
ORIGINAL ARTICLES Hert Filure in Outptients: Comoridities nd Mngement y Different Specilists. The EPISERVE Study José R. González-Juntey, Edurdo Alegrí Ezquerr, Vicente Bertoméu Mrtínez, c Pedro Conthe
More informationEFFECTS OF INGREDIENT AND WHOLE DIET IRRADIATION ON NURSERY PIG PERFORMANCE
Swine Dy 21 EFFECTS OF INGREDIENT AND WHOLE DIET IRRADIATION ON NURSERY PIG PERFORMANCE J. M. DeRouchey, M. D. Tokch, J. L. Nelssen, R. D. Goodbnd, S. S. Dritz 1, J. C. Woodworth, M. J. Webster, B. W.
More informationWhat Drives Prescribing of Asthma Medication to Children? A Multilevel Population-Based Study. Ann Fam Med 2009;7: DOI: /afm.910.
Wht Drives Prescribing of Asthm Mediction to Children? A Multilevel Popultion-Bsed Study Mir G. P. Zuidgeest, PhrmD, PhD 1,3 Liset vn Dijk, PhD 2 Peter Spreeuwenberg, MA 2 Henriëtte A. Smit, MD, PhD 3
More informationUniversity of Texas Health Science Center, San Antonio, San Antonio, Texas, USA
Lung Cncer Chemotherpy Given Ner the End of Life by Community Oncologists for Advnced Non-Smll Cell Lung Cncer Jose R. Murillo, Jr., Jim Koeller b,c Methodist Hospitl, Houston, Texs, USA; b University
More informationExpression of Three Cell Cycle Inhibitors during Development of Adipose Tissue
Expression of Three Cell Cycle Inhiitors during Development of Adipose Tissue Jiin Zhng Deprtment of Animl Sciences Advisor: Michel E. Dvis Co-dvisor: Kichoon Lee Development of niml dipose tissue Hypertrophy
More information3. DRINKING WATER INTAKE BACKGROUND KEY GENERAL POPULATION STUDIES ON DRINKING WATER INTAKE RELEVANT GENERAL POPULATION
3. DRINKING WATER INTAKE...1 3.1. BACKGROUND...1 3.2. KEY GENERAL POPULATION STUDIES ON DRINKING WATER INTAKE 1 3.3. RELEVANT GENERAL POPULATION STUDIES ON DRINKING WATER INTAKE...9 3.4. PREGNANT AND LACTATING
More informationClinical Policy: ACEI and ARB Duplicate Therapy Reference Number: CP.PMN.61 Effective Date: Last Review Date: 05.18
Clinical Policy: Reference Number: CP.PMN.61 Effective Date: 08.01.14 Last Review Date: 05.18 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important regulatory
More informationTable W in S1 File. Tentative breed-specific reference intervals for the Cavalier King Charles Spaniels
Tble V in S1 File. Tenttive breed-specific reference intervls for the Lbrdor Retriever (n=327; 19 intct femles, 98 neutered femles, 91 intct mles nd 119 neutered mles). The medin (minimum, mximum) ge ws
More informationWater fl uoridation and dental caries in 5- and 12-year-old children from Canterbury and Wellington
18 10 NEW ZEALAND DENTAL JOURNAL MARCH 004 Wter fl uoridtion nd dentl cries in 5- nd 1-yer-old children from Cnterbury nd Wellington MARTIN LEE AND PETER J DENNISON New Zelnd Dentl Journl 100, No. 1: 10-15;
More informationSTATE OF NEW YORK DEPARTMENT OF HEALTH
STATE OF NEW YORK DEPARTMENT OF HEALTH Corning Tower The Governor Nelson A. Rockefeller Empire State Plaza Albany, New York 12237 Antonia C. Novello, M.D., M.P.H., Dr.P.H. Commissioner Dennis P. Whalen
More informationLongitudinal Association of Maternal Attempt to Lose Weight During the Postpartum Period and Child Obesity at Age 3 Years
nture publishing group Longitudinl Assocition of Mternl Attempt to Lose Weight During the Postprtum Period nd Child Obesity t Age 3 Yers Kendrin R. Sonneville 1,2, Sheryl L. Rifs-Shimn 3, Emily Oken 3,
More informationSUSPECT ADVERSE REACTION REPORT
CIOMS FORM SUSPECT ADVERSE REACTION REPORT DE-BFARM-16390235 I. REACTION INFORMATION 1. PATIENT INITIALS 1. COUNTRY 2. DATE OF BIRTH 2. AGE 3. SEX 4-6 REACTION ONSET privcy (10000059): Abdominl discomfort
More informationSUPPLEMENTARY INFORMATION
doi:1.138/nture1794 BR EPFs BRI1? ERECTA TMM BSKs YDA PP2A BSU1 BIN2 pbzr1/2 BZR1/2 MKK4/5/7/9 MPK3/6 SPCH Cell growth Stomtl production Supplementry Figure 1. The model of BR nd stomtl signling pthwys.
More information